Kane Biotech Inc. (KNBIF)
OTCMKTS · Delayed Price · Currency is USD
0.0290
-0.0035 (-10.77%)
Feb 12, 2026, 11:21 AM EST
Kane Biotech Market Cap
Kane Biotech has a market cap or net worth of $5.35 million as of February 12, 2026. Its market cap has decreased by -46.92% in one year.
Market Cap
5.35M
Enterprise Value
6.34M
Revenue
412.72K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since May 20, 2003, Kane Biotech's market cap has increased from 764.76K to 5.35M, an increase of 598.93%. That is a compound annual growth rate of 8.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 4.66M | -12.04% |
| Dec 30, 2025 | 5.30M | -49.58% |
| Dec 31, 2024 | 10.51M | 31.63% |
| Dec 29, 2023 | 7.99M | -3.79% |
| Dec 30, 2022 | 8.30M | -40.97% |
| Dec 31, 2021 | 14.06M | 17.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 7.44M |
| Synlogic | 7.17M |
| LakeShore Biopharma | 6.63M |
| Brainstorm Cell Therapeutics | 6.29M |
| GPL Holdings | 5.83M |
| Bioxytran | 5.30M |
| AXIM Biotechnologies | 4.99M |
| Enzon Pharmaceuticals | 4.79M |